Effer-K Meets Medscape at the AAFP FMX in Orlando, FL

We had great success exhibiting Effer-K at the AAFP FMX (Family Medicine Experience) in Orlando, FL last month. Not only did we have the opportunity to discuss the significant benefits of prescribing Effer-K with the many physicians in attendance, we also had the pleasure of meeting the exhibitors for Medscape. According to the Medscape website, Medscape is the leading online global destination for physicians and healthcare professionals worldwide. They offer the latest medical news, expert perspectives, essential point-of-care drug and disease information, relevant professional education, and CME.1

medscapeSince Medscape was exhibiting at a nearby booth, we saw this as a great opportunity to discuss the mutual benefit of listing Effer-K in their database. Fortunately, Medscape agreed that their members should have access to information about Effer-K, and they wasted no time in adding Effer-K to their prescription drug list. (We learned Effer-K had been added to the potassium bicarbonate/potassium citrate monograph soon after we returned from Orlando.) Because we are confident Medscape members will find huge value in the addition of Effer-K to the database, we are excited Medscape recognized the value and chose to add Effer-K.

We are thrilled to be listed on Medscape!

1) http://www.medscape.com/public/about

Effer-K is now listed in Epocrates!

effer-k-epocratesIt has only taken two years, countless emails and a few face-to-face meetings – but we are now happy to announce that Effer-K is listed in Epocrates!  (We get it – they are busy…)

Epocrates is “the #1 medical reference app” used by more than “one million health care providers.”  Almost any information pertaining to a prescription drug is available in the Epocrates database, including indications, dosing protocol and dangerous interactions.  It’s popularity became increasingly apparent to us as we were frequently asked when meeting physicians, “why can’t I find you in Epocrates….”  Well – now you can.

Thank you to the team at Epocrates who helped to get us listed.

Potassium Citrate shown to help alleviate and prevent gout “attacks”

Gout, the buildup of uric acid in your body, is a painful condition which affects an estimated 6 million Americans. Men over the age of 40 are at the biggest risk. This condition is caused when the body is unable to process purines or when you kidneys are unable to remove the uric acid from your blood stream.

In either case, high levels of uric acid can lead to the build up of uric crystals in your joints, typically in your big toe but other small joints can also be affected.

The symptoms of a gout attack are, from WebMD.com:

  • Warmth, pain, swelling, and extreme tenderness in a joint, usually a big toe joint. This symptom is called podagra. Symptoms sometimes start in a different joint, such as the ankle or knee.
  • Pain starts during the night and is so intense that even light pressure from a sheet is intolerable.
  • Rapid increase in discomfort, lasting for some hours of the night and then easing during the next few days.
  • As the gout attack subsides, the skin around the affected joint may peel and feel itchy.

Other symptoms may include:

  • Very red or purplish skin around the affected joint, which may appear to be infected.
  • Limited movement in the affected joint.

Potassium citrate, such as Effer-K®, helps control the symptoms of gout. This is because potassium is very alkaline, and when it is consumed it raises urine pH which may aid in releasing uric acid from the blood stream and prevent a gout attack.  Potassium citrate (in a liquid form) as opposed to potassium chloride (in a tablet or capsule form) is better than for the treatment of gout because it’s easier for the body to absorb.

If you have prolonged high levels of uric acid in your body, there is a 20% chance or higher that you body will start to form kidney stones. To prevent this, potassium citrate is used to raise the pH levels of urine up to 6.8 mg/dL(0.401 mmol/L) for men, and 6.0 mg/dL(0.354 mmol/L) for women. This level of pH in urine is referred to as alkaline urine.

Potassium citrate has also been found to help the body break down kidney stones that have already started forming and has been proven to help prevent future gout “attacks”.





Effer-K a Friend to the Calorie Watcher

Effer-K is a Friend to the Calorie Watcher

We recently had a physician from BJC Health Care ask us if Effer-K would be suitable for individuals watching their caloric intake.  This physician knew that Effer-K is a reliable means to replenish potassium levels, but what about the calories??  Fortunately, we have some good news.

Effer-K comes in three different dosages: 10, 20 and 25 mEq with a variety of 8 flavors between the three dosages. Below is a chart of all the Effer-K dosages and the corresponding number of calories.  Pretty miniscule.

Effer-K Products Calories
Effer-K 10 mEq Unflavored 2.4
Effer-K 10 mEq Cherry Vanilla 2.3
Effer-K 20 mEq Unfavored 4.8
Effer-K 20 mEq Orange Cream 4.5
Effer-K 25 mEq Unflavored 6.0
Effer-K 25 mEq Lemon Citrus 5.7
Effer-K 25 mEq Orange 5.4
Effer-K 25 mEq Cherry Berry 5.4

We try to answer all questions physicians and patients may have about Effer-K, so if there additional information we can help with, please feel free to contact us or comment on this post. We will respond and get back to you as soon as possible.

Potassium citrate and uric acid

Managing uric acid is an issue for people with many different medical conditions. High uric acid is caused by gout, kidney stones, Lesch-Nyhan syndrome, cardiovascular disease, diabetes and metabolic syndrome and patients must take medication to lower their uric acid.  Uric acid can not get too low, however because low uric acid can cause multiple sclerosis (MS)

In the article Successful management of uric acid nephrolithiasis with potassium citrate; which can be read here, http://www.nature.com/ki/journal/v30/n3/abs/ki1986201a.html, researchers describe how eighteen  people with uric acid nephrolithiasis  were treated with potassium citrate for a maximum of 5 years and 4 months. Over this time the dosage was anywhere from 30 mEq to 80 mEq per day.  The result was that no new stones were formed and stones urinary pH increased from low (acidic) to normal. The conclusion drawn from this study is that uric acid nephrolithiasis can be successfully managed with potassium citrate.

We found this article interesting because Effer-K is potassium citrate, therefore it identifies additional benefits of Effer-K beyond increasing potassium levels.


Back to Top